Hsinchu, Taiwan

Kun-Che Li


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Kun-Che Li in Alzheimer's Disease Treatment

Introduction

Kun-Che Li is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of Alzheimer's disease treatment through his innovative patents. With a total of two patents to his name, his work focuses on advanced techniques for early detection and treatment of this debilitating condition.

Latest Patents

Kun-Che Li's latest patents include an electrochemical dephosphorylation technique for treating Alzheimer's disease and color-changing eye drops for early screening of the disease. The electrochemical dephosphorylation technique involves a gold electrode that operates at a negative potential of -0.2 V to -0.6 V. This innovative approach aims to provide a new method for treating Alzheimer's disease. The color-changing eye drops are designed for early screening and contain Aβ aptamer-gold nanoparticles mixed with a pharmaceutically acceptable carrier. This formulation allows for the analysis of color changes in tear samples, which can help determine the concentration of Aβ present in the test subject's tears.

Career Highlights

Kun-Che Li is affiliated with National Yang Ming Chiao Tung University, where he continues to advance research in the field of Alzheimer's disease. His work is characterized by a commitment to developing practical solutions that can improve the lives of those affected by this condition.

Collaborations

Some of his notable coworkers include Jung-Chih Chen and I-Chiu Li, who collaborate with him on various research projects aimed at enhancing the understanding and treatment of Alzheimer's disease.

Conclusion

Kun-Che Li's innovative patents and research efforts represent a significant advancement in the fight against Alzheimer's disease. His contributions are paving the way for new diagnostic and therapeutic options that could greatly benefit patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…